Publication | Open Access

Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients

OncologyMedicineReceptor Tyrosine KinaseMulti Kinase InhibitorAnti-cancer AgentCancer PatientsPharmacologyCell BiologyTumor MicroenvironmentCancer ResearchCancer GrowthPlasma Protein Binding